| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JNR.21558 |
| P698 | PubMed publication ID | 18183615 |
| P2093 | author name string | Li-Bo Liu | |
| Yi-Xue Xue | |||
| Yun-Hui Liu | |||
| Yi-Bao Wang | |||
| P2860 | cites work | Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation | Q37569899 |
| Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. | Q46582455 | ||
| Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. | Q50769501 | ||
| P433 | issue | 5 | |
| P921 | main subject | cytoskeleton | Q154626 |
| P304 | page(s) | 1153-1168 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton | |
| P478 | volume | 86 |
| Q39025229 | Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases |
| Q39873912 | Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration |
| Q48313363 | Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway |
| Q37573461 | Cancer and the metastatic substrate |
| Q37253945 | Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells |
| Q39116577 | Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke |
| Q38670273 | Cofilin as a Promising Therapeutic Target for Ischemic and Hemorrhagic Stroke |
| Q38617017 | Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability |
| Q38851989 | D-Peptides as Recognition Molecules and Therapeutic Agents |
| Q49164677 | Disruption of Intracellular ATP Generation and Tight Junction Protein Expression during the Course of Brain Edema Induced by Subacute Poisoning of 1,2-Dichloroethane |
| Q45833674 | Effect of Robo4 on retinal endothelial permeability |
| Q33686454 | Effect of cAMP derivates on assembly and maintenance of tight junctions in human umbilical vein endothelial cells. |
| Q39856778 | Effect of thrombin and bradykinin on endothelial cell mechanical properties monitored through membrane deformation |
| Q52689356 | Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. |
| Q48917184 | Evidence for involvement of ROCK signaling in bradykinin-induced increase in murine blood-tumor barrier permeability |
| Q42271585 | Exacerbation of DSS-induced colitis in mice lacking kinin B(1) receptors through compensatory up-regulation of kinin B(2) receptors: the role of tight junctions and intestinal homeostasis |
| Q28282373 | Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications |
| Q54118354 | Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. |
| Q46456513 | Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus |
| Q38730069 | In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. |
| Q37984531 | Kinin receptors as targets for cancer therapy. |
| Q36528998 | Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation |
| Q48374792 | Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism |
| Q35539250 | Mast cell activation is involved in stress-induced epithelial barrier dysfunction in the esophagus |
| Q39463653 | Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier |
| Q48732717 | Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin |
| Q92733028 | Metformin as Potential Therapy for High-Grade Glioma |
| Q40823291 | MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε. |
| Q38264654 | MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII. |
| Q33823616 | Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator |
| Q36651592 | Nanomedicines for Endothelial Disorders |
| Q30420484 | Noise alters guinea pig's blood-labyrinth barrier ultrastructure and permeability along with a decrease of cochlear Claudin-5 and Occludin |
| Q37855817 | Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier |
| Q35734471 | Novel treatment strategies for brain tumors and metastases |
| Q99238190 | Orthohantavirus Pathogenesis and Cell Tropism |
| Q93167493 | RBFOX1 Regulates the Permeability of the Blood-Tumor Barrier via the LINC00673/MAFF Pathway |
| Q50116104 | Relationship between G proteins coupled receptors and tight junctions |
| Q46103277 | RhoA-mediated potential regulation of blood-tumor barrier permeability by bradykinin |
| Q39084721 | Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression |
| Q39359239 | Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier |
| Q35525050 | Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers |
| Q95651532 | StatinImplications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders |
| Q38233077 | Strategies for overcoming the blood-brain barrier for the treatment of brain metastases |
| Q30768284 | Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties |
| Q41024288 | The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB. |
| Q47222248 | The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier |
| Q38743460 | The challenges associated with molecular targeted therapies for glioblastoma |
| Q38863697 | The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144 |
| Q27302299 | The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin |
| Q37327736 | The role of histamine in opening blood-tumor barrier |
| Q34087938 | The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice |
| Q23917931 | Uptake of materials from the nasal cavity into the blood and brain: are we finally beginning to understand these processes at the molecular level? |
| Q38958450 | miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5. |
Search more.